Invention Grant
- Patent Title: Antibody-dependent cell-mediated phagocytosis assay for reliably measuring uptake of aggregated proteins
-
Application No.: US16083695Application Date: 2017-03-14
-
Publication No.: US11340225B2Publication Date: 2022-05-24
- Inventor: Carl Co , Allyson Masci , Svetlana Bergelson
- Applicant: Biogen International Neuroscience GmbH
- Applicant Address: CH Baar
- Assignee: Biogen International Neuroscience GmbH
- Current Assignee: Biogen International Neuroscience GmbH
- Current Assignee Address: CH Baar
- Agency: Choate, Hall & Stewart LLP
- Agent Stephanie L. Schonewald; Tracy L. Vrablik
- International Application: PCT/EP2017/056031 WO 20170314
- International Announcement: WO2017/157961 WO 20170921
- Main IPC: G01N33/569
- IPC: G01N33/569 ; G01N33/50

Abstract:
The present disclosure provides methods of assaying for antibody-dependent cell-mediated phagocytosis (ADCP). In some embodiments, the methods include monomerizing and labeling a protein, contacting the protein with a protein-specific antibody to form an antibody-protein complex, contacting the antibody-protein complex with a phagocytic cell to permit phagocytosis, and assessing the amount of internalized fluorescence.
Public/Granted literature
- US20190079077A1 ANTIBODY-DEPENDENT CELL-MEDIATED PHAGOCYTOSIS ASSAY FOR RELIABLY MEASURING UPTAKE OF AGGREGATED PROTEINS Public/Granted day:2019-03-14
Information query
IPC分类: